vimarsana.com
Home
Live Updates
Sana Biotechnology Announces Preclinical Data Published in S
Sana Biotechnology Announces Preclinical Data Published in S
Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the immune system Similar hypoimmune primary human... | April 12, 2023
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Steve Harr ,
Exchange Commission ,
Nasdaq ,
Sana Biotechnology Inc ,
Company Securities ,
Science Translational Medicine ,
Islet Cells Survive ,
Escape Allogeneic ,
Cells Control Insulin Similarly ,
Unedited Wild Type Islet Cells ,
Cells Ameliorate Diabetes ,
Humanized Autoimmune Mice ,
South San Francisco ,
Sana Biotechnology ,
Annual Report ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Ypoimmune ,
Human ,
Islet ,
Cells ,
Normalized ,
Glucose ,
N ,
Diabetic ,
Ahumanized ,
Immunocompetent ,
House ,
Model ,
End ,
Aavoided ,
Allogeneic ,
Autoimmune ,
Rejection ,
Y ,
The ,
Immune ,
System ,
Similar ,
Rimary Sana Us7995661045 ,